Presentation is loading. Please wait.

Presentation is loading. Please wait.

NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors

Published byἭβη Βικελίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors"— Presentation transcript:

1 NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors
Iacopo Petrini, MD, Christopher A. French, MD, Arun Rajan, MD, Michael J. Cameron, MSC, Elaine S. Jaffe, MD, Paolo A. Zucali, MD, Jianwu Xie, MD, PhD, Yisong Wang, PhD, Giuseppe Giaccone, MD, PhD  Journal of Thoracic Oncology  Volume 7, Issue 4, Pages (April 2012) DOI: /JTO.0b013e f8f Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 NUT in thymic carcinoma. A, Survival analysis of thymic carcinoma patients. Left, Overall survival curve of thymic carcinoma patients (median: 48 months). Middle, Overall survival by differentiation status. Right, Overall survival by metastasis status. Survival curves were generated using the Kaplan-Meier method. Met, metastasis; Nonmet, nonmetastasis; Diff, differentiated; Undiff, undifferentiated. B, Computed tomography of the thymic carcinoma patient with NUT rearrangement: left supraclavicular lymph nodes, primary bulky mediastinal mass, and para-aortic lymph nodes. C, NUT immunohistochemistry. NUT-positive (left) and -negative (right) thymic carcinomas. Note that in the thymic carcinoma with NUT rearrangement, the speckled NUT expression was mainly restricted in the undifferentiated cell nuclei and much less NUT was in the differentiated squamous cell area. D, NUT gene rearrangement in a thymic carcinoma. Dual-color split-apart fluorescence in situ hybridization was performed with probes flanking 5' centromeric (red) and 3' telomeric (green) of NUT, BRD3, and BRD4, respectively, as described previously.21 Arrows (left panel) marked split-apart NUT signals (red/green signals were split apart due to NUT rearrangement), whereas no BRD3 (not shown) or BRD4 split-apart signal (right panel) was detected in the same tumor sample, indicating that the NUT rearrangement did not involve BRD3/4. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e f8f) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Thymic carcinoma with a basaloid component. A, Mediastinal tumor cells with NUT rearrangement infiltrate in the fibrous stroma. Keratinization is seen (H&E; ×200). B, Keratin immunohistochemistry. Tumor cells are strongly and uniformly positive (AE1/AE3 immunostain; ×200). C, p63 shows positive staining mainly in the basaloid component (p63;×200). D, Epithelial cells also express CD5 (CD5; ×200). Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e f8f) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors"

Similar presentations

NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors Iacopo Petrini, MD, Christopher A. French, MD, Arun Rajan, MD, Michael J. Cameron, MSC,

NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors Iacopo Petrini, MD, Christopher A. French, MD, Arun Rajan, MD, Michael J. Cameron, MSC,
Naomi Fujioka, MD, Christopher A. French, MD, Michael J

Naomi Fujioka, MD, Christopher A. French, MD, Michael J
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Primary Mucoepidermoid Carcinoma of the Esophagus

Primary Mucoepidermoid Carcinoma of the Esophagus
Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization.

Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization.
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma  Daniel L. Albertus, BS, Christopher.

AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma  Daniel L. Albertus, BS, Christopher.
Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell.

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell.
Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy  Deepa Rangachari, MD, Xiuning.

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy  Deepa Rangachari, MD, Xiuning.
Heterogeneity of Anaplastic Lymphoma Kinase Gene Rearrangement in Non–Small-Cell Lung Carcinomas: A Comparative Study Between Small Biopsy and Excision.

Heterogeneity of Anaplastic Lymphoma Kinase Gene Rearrangement in Non–Small-Cell Lung Carcinomas: A Comparative Study Between Small Biopsy and Excision.
Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer  Wolf Köster, MD, Andrea Heider, MD, Norbert.

Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer  Wolf Köster, MD, Andrea Heider, MD, Norbert.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.
Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer  Anish Thomas, MD, Jih-Hsiang Lee, MD, Zied Abdullaev, PhD, Kang-Seo.

Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer  Anish Thomas, MD, Jih-Hsiang Lee, MD, Zied Abdullaev, PhD, Kang-Seo.
FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma  Sandra Salvi, PhD, Serena Varesano, PhD, Simona Boccardo, PhD, Jean Louis.

FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma  Sandra Salvi, PhD, Serena Varesano, PhD, Simona Boccardo, PhD, Jean Louis.
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Anja C. Roden, MD, Patricia T. Greipp, DO, Darlene L. Knutson, Sara M

Anja C. Roden, MD, Patricia T. Greipp, DO, Darlene L. Knutson, Sara M
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 

Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 
Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma  Naoki Yanagawa, MD, PhD, Charles.

Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma  Naoki Yanagawa, MD, PhD, Charles.
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations  Lynette M. Sholl, MD, Mizuki Nishino, MD, Saraswati.

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations  Lynette M. Sholl, MD, Mizuki Nishino, MD, Saraswati.

Similar presentations

Ads by Google